DGAT2 and fatty liver disease: In studies of hepatic steatosis, mice over-expressing DGAT2, an enzyme that catalyzes the final step of hepatic triglyceride biosynthesis, was demonstrated to develop hepatic steatosis with normal plasma glucose and insulin levels and normal insulin tolerance (12).